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Prevalence and causes of albuminuria in non-insulin-dependent dia-
betic patients. A prospective study of the prevalence and causes of
persistent albuminuria (>300 mg/24 hr) was conducted in non-insulin-
dependent diabetic (NIDDM) patients, age <66 years, attending a
diabetic clinic during 1987. All eligible patients (N = 370) were asked to
collect at least one 24-hour urine sample for albumin analysis. Urine
collection was obtained in 224 males and 139 females (98%). Fifty
patients (7 women) suffered from persistent albuminuria (13.8%). The
prevalence of albuminuria was significantly higher in males (19%) than
in females (5%). A kidney biopsy was performed in 35 patients (70%).
The kidney biopsies revealed diffuse and/or nodular diabetic glomeru-
losclerosis in 27 patients (77%), while the remaining eight patients (23%)
had a variety of non-diabetic glomerulopathies, such as minimal lesion
and mesangioproliferative glomerulonephritis. Diabetic retinopathy
was present in 15 of 27 patients (56%) with diabetic glomerulosclerosis,
while none of the eight patients with a non-diabetic glomerulopathy had
retinopathy. Our cross sectional study has revealed a high prevalence of
albuminuria and of non-diabetic glomerulopathy as a cause of this
complication in NIDDM patients. Presence of diabetic retinopathy
strongly suggests that a diabetic glomerulopathy is the cause of albu-
minuria. Albuminuric non-insulin-dependent diabetic patients without
retinopathy require further evaluation, that is, kidney biopsy.
Thirty to 40 percent of all diabetics, whether insulin-depen-
dent or not, develop persistent proteinuria [1—4]. Persistent
proteinuria is the hallmark of diabetic nephropathy which can
be diagnosed clinically if the following additional criteria are
fulfilled: presence of diabetic retinopathy and no clinical or
laboratory evidence of kidney or renal tract disease other than
diabetic glomerulosclerosis 15, 6]. The validity of this clinical
definition of diabetic nephropathy is well established in insulin-
dependent diabetic (IDDM) patients [5, 6], while we are still
lacking confirmation in non-insulin-dependent diabetic
(NIDDM) patients. Furthermore, the prevalence of non-dia-
betic renal lesions has been reported much higher in selected
series of proteinuric NIDDM patients (about 30%) as compared
with proteinuric IDDM patients (approximately 5%) [5, 7—9].
This heterogeneity may explain why there is considerable
variation in the natural history and clinical course of so-called
"diabetic nephropathy" in NIDDM patients [10].
The aim of our prospective study was to determine the
prevalence and causes of persistent albuminuria (>0.3 g124 hr)
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in NIDDM patients below 66 years of age. Kidney biopsies
were performed in all eligible proteinuric NIDDM patients.
Methods
Patients
In a recent cross sectional study of all (139 females and 224
males) non-insulin-dependent diabetic patients less than 66
years of age, attending HvidOre Hospital during 1987, we
identified 50 patients (seven women) with persistent albumin-
uria (300 mg124 hr) [11]. Persistent albuminuria was defined as
urinary albumin excretion 300 mg/24 hr in at least three
consecutive, sterile, non-ketotic 24-hour urine samples. Dia-
betic patients were regarded as suffering from non-insulin-
dependent diabetes if they were treated by diet alone, or diet
combined with oral hypoglycemic drugs, or if they were treated
with insulin and had an onset of diabetes after the age of 40 and
a body weight in excess of the ideal body weight at the time of
diagnosis [12]. Insulin treated lean patients (<100% ideal body
weight) had a glucagon test performed, and non-insulin-depen-
dent diabetes was diagnosed if the stimulated C-peptide value
was 0.60 pmol/ml [12]. The glucagon/C-peptide test was
carried out after an overnight fast. Blood samples for plasma
C-peptide determination were obtained before and six minutes
after an intravenous bolus injection of I mg glucagon (Novo
Nordisk, Bagsvaerd, Denmark) as described previously [131.
All 50 proteinuric patients were referred to the departments
of nephrology for further examination, except six patients who
did not want further evaluation. Two patients did not attend,
and kidney biopsy could not be performed due to: anticoagulant
treatment in two patients, and a solitary kidney in four patients
[nephrectomy (N = 2), aplasia (N = 2)]. A renal biopsy was
performed in the remaining 36 patients.
Methods
Albuminuria was determined by radioimmunoassay with a
single antibody [14]. Sterility of urine was checked by quanti-
tative culture. If bacterial growth was found, urine collection
was repeated after treatment. Microscopic examination of the
urinary sediment was performed in a midstream specimen in all
patients with persistent albuminuria. Eight ml of urine was
centrifuged at 1500 rpm for five minutes. The supernatant was
removed, and resuspended sediment (approximately 0.15 ml)
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a Some patients with nephropathy receiving antihypertensive treat-
ment had albuminuria below 0.3 g!24 hrb Range
was examined on a slide with phase-contrast microscopy.
Significant hematuria is defined as three or more erythrocytes
per high power field urinalysis of two or more sterile urine
samples. Glomerular filtration rate (GFR) was measured in all
patients, using a single intravenous injection of 100 jsCi 51Cr-
EDTA at 9 a.m., with determination of plasma radioactivity in
venous blood samples taken 180, 200, 220 and 240 minutes after
the injection [15].
Arterial blood pressure was measured three times in the
sitting position after 10 minutes of rest. The measurements were
carried out with an automatic electronic device (Takeda Medi-
cal UA-751, Tokyo, Japan), cuff size 25 x 12 cm in lean adults
and 30 x 15 cm in obese patients. Arterial hypertension was
diagnosed according to the World Health Organization's crite-
ria ( 160/95 mm Hg) or if antihypertensive treatment was being
prescribed. Hemoglobin A1 (DIAMAT Analyzer, BlO-RAD,
California, USA) was determined. Normal range for HbA1C was
4.1 to 6.1%. Ophthalmoscopy and fundus photography (Canon
CFD-60Z, Kawasaki, Japan) through dilated pupils were car-
ried out in all patients. Autonomic neuropathy was diagnosed if
beat-to-beat variation in heart rate during hyperventilation was
l5 beats per mm [16]. Body mass index (weight/height2) was
calculated.
A renal biopsy was performed in 36 patients. Insufficient
material was obtained in one patient. All biopsies were re-
viewed by two observers who were unaware of the clinical
features.
Light microscopy. The tissue was fixed in 4% formaldehyde
buffered to pH 7.0 ("Lithe's fluid"), embedded in Paraplast®
Histological classification of the glomerular lesions was ac-
cording to the World Health Organization standard [18]. The
following definition of histological entities was applied:
<0.005 Diabetic glomeruloscierosis (glomerulopathy): Diffuse.
Global and diffuse widening of the mesangial regions with a
13 <0.005 delicately fibrillar appearance showing radiating finger-like ex-
tensions from the glomerular pole (if represented in the glomer-
ular cross section).
Nodular. Mesangial areas with a large central acellular or
nearly acellular region surrounded by a rim of nuclei or small
extended marginal capillary.
Degree of severity of the diabetic lesions in the glomeruli was
estimated (from 1 to 3) by the amount of matrix in mesangium
of non-sclerosed glomeruli.
Non-diabetic glomerular lesions: Minimal lesion. Glomeruli
were normal or a slight global and diffuse mesangial hypercel-
lularity (a maximum of 4 cell nuclei) associated with negative
immunofluorescence and absence of glomerular deposits by
electron microscopy.
Mesangioprolferative glomerulonephritis. Global and diffuse
mesangial hypercellularity with a number of cell nuclei more
than nine in the mesangial segments [191 associated with global
and diffuse distribution of immunoglobulins and/or C3 in the
glomeruli [20].
Glomerulonephritis sequelae. Global mesangial widening
with fibrous adhesions between some of the capillary loops and
the inner side of the capsule of Bowman associated with a
diffuse distribution of immunoglobulin and C3 in the glomeruli.
Statistical analysis
Values are expressed as mean SD or median with range in
parenthesis. For evaluating frequencies, the chi-squared test
was used and for evaluating continuous variables the Mann-
Whitney test was used for comparison between the two groups.
A P value (two tailed) <0.05 was considered significant.
Results
Our cross sectional study showed a prevalence of albumin-
uria of 13.8% (50/363 patients). The prevalence of albuminuria
was significantly higher in males (19%) than in females (5%), P
<0.005.
(Fisher Company, Fair Lawn, New Jersey, USA) cut into 4, 3
and 2 pm sections and stained with hemotoxylin-eosin, period-
Glomerulopathy ic-acid Schiff, picric acid + sirius red Masson's trichrome and
Diabetic Non-diabetic value silver methenamine + hematoxyhin-eosin.
Immunofluorescent microscopy. Kidney specimens were fro-
I F/26 M 1 F/7 M zen using dry ice, embedded in Tissue-Teck (Miles, Naperville,55±9 56±8 . . . .
30 7 30 6 3 Illinois, USA) gelatin, and sections of 2 iim were cut at —24 C
15/55/30 38/62/0 on a Leitz Histocryotome (Wetzlar, Germany). Direct immu-
nofluorescent staining technique was applied, using FITC-
conjugated rabbit or goat antisera specifically reactive to human
iO(1...27) 9431)5 IgG, 1gM, IgA as well as complement C1q, C3 and C4 [17].Electron microscopy. Tissue was available in 24 out of the 35
6 (0—17) 0 (0—5) <o.os kidney biopsies. The tissue was fixed in 3% glutaraldehyde at
pH 7.4, followed by dehydration in increasing concentrations of
ethanol, after fixation in 1% osmium tetroxide, and embedded
1.9(0.2—11.4) 1.4(0.9—3.9) .in Epon. Ultra-thin sections were cut on an LKB I ultramicro-
96 23 <0.05 tone and examined on a Philips 100 electron microscope.
(43_120)L
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Table 2. Renal pathology in 35 non-insulin-dependent diabetic patients with persistent albuminuria
Immunofluorescence microscopyLight and electron microscopy
.Patient
no.
Diabetic Grading Non-diabetic Immune deposits .Localization in glomeruliglomerulo- of No. glomerular Immuno- Complement-
sclerosis severity G/S lesions globulins fractions Mesangium Capillary Global Segmental
01 Diffuse 1 17/0 Absent 0 0 — —
02 Absent 20/1 GN, 1gM 0 + + + —
sequelae
03 Diffuse 2 15/3 Absent 0 0 — — — —
04 Absent 8/1 Mm. lesion 0 0 — — — —
05 Nodular 3 17/1 Absent No tissue
06 Absent 8/0 Mesangio- 0 C3 + + + —
prolif. UN
07 Nodular 2 10/1 Absent 0 0 — — — —
08 Diffuse 2 35/5 Absent 1gM, IgA 0 + + — +
09 Diffuse 1 15/4 Absent 0 C3 — + — +
10 Diffuse 1 21/4 Absent No tissue
II Absent 10/1 Mm. lesion 0 0 — — — —
12 Absent 22/1 Mesangio- 1gM, IgA 0 + — + —
prolif. GN
13 Diffuse 1 24/1 Absent 0 0 — — — —
14 Diffuse 2 22/4 Absent No tissue
15 Diffuse 2 40/25 Absent 0 0 — — —
16 Diffuse 1 8/1 Mesangio- 1gM, IgA C3 + + + —
prolif. ON
17 Diffuse 2 10/2 Absent No tissue
18 Absent 4/0 Mm. lesion 0 0 — — — —
19 Absent 12/1 Mm. lesion 0 0 — — — —
20 Nodular 2 53/23 Absent 0 0 — — — —
21 Nodular 3 16/7 Absent IgO, IgA 0 + + — +
22 Diffuse 1 15/2 Absent 1gM, IgA 0 + + + +
23 Diffuse 2 22/14 Absent 0 C3 + + — +
24 Nodular 2 8/2 Absent No tissue
25 Nodular 2 15/6 Absent IgG, 1gM 0 — + — +
26 Diffuse 1 33/3 Absent 1gM, IgA C3 + + — +
27 Diffuse 2 10/0 Absent 0 0 — — — —
28
29
Diffuse 1 13/4 Absent 1gM C1 + + —Diffuse 1 10/0 Absent 0 0 — — —
+
—
30 Nodular 3 4/2 Absent No tissue
31 Diffuse 1 17/7 Absent No tissue
32 Diffuse 1 51/3 Absent 1gM 0 + + + —
33 Nodular 3 18/12 Absent 1gM C3 + + — +
34 Diffuse 1 7/0 Absent IgG, 1gM C3 + + — +
35 Diffuse 1 48/0 Absent 0 0 — — — —
glomeruli; S, sclerosed; Mm., minimal; GN, glomerulonephritis; Mesangioprolif., mesangioproliferative. Slight = 1,Abbreviations are: G,
medium = 2, severe = 3.
A kidney biopsy was performed in 35 of the albuminuric
patients and their clinical characteristics and pertinent labora-
tory findings are shown in Table 1. There were no significant
differences in sex, age, body mass index, anti-diabetic treat-
ment, hemoglobin A1, known duration of diabetes, or preva-
lence of hypertension between proteinuric patients with or
without diabetic glomerulopathy. The majority of patients with
a non-diabetic glomerulopathy had albuminuria already at the
time of diagnose of diabetes. Lack of retinopathy and a low
prevalence of autonomic neuropathy also characterized these
patients. Diabetic glomeruloscierosis was found in all (N = 15)
our albuminuric diabetic patients suffering from diabetic reti-
nopathy. Thus, the diagnostic specificity (predictive value of a
positive test) of retinopathy is 100% (15/15) while the diagnostic
sensitivity (predictive value of a negative test) is only 40%
(8/20), Forty-one percent of our patients with biopsy proven
diabetic glomerulopathy lacked diabetic retinopathy. Four pa-
tients with diabetic glomerulosclerosis and well-preserved kid-
ney function (GFR: 45, 51, 55 and 100 ml/min/l.73 m2) had
persistent hematuria.
The histological findings, deposits of immunoglobulins and
complement fractions and their localization are shown in Table
2. Nineteen patients had a diffuse diabetic glomerulosclerosis
and eight suffered from a nodular diabetic glomeruloscierosis.
One patient had a mesangioproliferative glomerulonephritis
superimposed on a diffuse diabetic glomerulosclerosis. Four
patients had minimal lesion nephropathy, two patients suffered
from mesangioproliferative glomei-ulonephritis, and one patient
had sequelae after a glomerulonephritis.
Discussion
Our cross sectional study showed a prevalence of albumin-
uria of 13.8% in NIDDM patients less than 66 years of age. The
prevalence of persistent albuminuria was four times higher in
males than in females. Histological examinations demonstrated
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that non-diabetic glomerulopathies accounted for approxi-
mately one quarter of all our cases with persistent albuminuria.
These patients were characterized clinically by: lack of retinop-
athy, low prevalence of autonomic neuropathy, and a short time
interval between onset of diabetes and of albuminuria,
Since our study was not a survey based on the general
population, selection bias might have been a confounding
variable. Selective referral cannot be excluded, since 30% of
our patients had albuminuria at the time of referral. However,
the prevalence of albuminuria in relation to known duration of
NIDDM is practically identical with the results obtained in two
surveys based on a general population revealing a prevalence of
albuminuria of 12% and 15%, respectively [21, 22]. We have no
evidence suggesting that the patients who dropped out were
unrepresentative of the group as a whole except those with
albuminuria (excess mortality).
The male predominance of proteinuric patients was more
marked in the present study as compared to previous investi-
gations [4, 21, 22]. A male predominance has also been docu-
mented in proteinuric IDDM patients [1, 2]. The prevalence of
non-diabetic kidney diseases in proteinuric NIDDM patients is
approximately 30% [7—9]. This finding is based on retrospective
studies of kidney biopsy specimens. In all three studies renal
biopsy was performed because of abnormal urine sediment,
particularly increased number of erythrocytes or casts, lack of
retinopathy, or other findings inconsistent with either the clin-
ical expression or the natural history of diabetic nephropathy.
These selection criteria will lead to an overestimation of the real
prevalence of non-diabetic kidney diseases in proteinuric
NIDDM patients. This suggestion is supported by the finding of
a lower prevalence (23%) of non-diabetic glomerulopathies in
our prospective study, where no special selection criteria were
applied. The prevalence of non-diabetic kidney diseases in
proteinuric IDDM patients is approximately 5% [5]. The dis-
covery of a non-diabetic kidney disease in a proteinuric diabetic
patient may have an effect on the prognosis and may alter the
therapy for the renal disease. However, no alteration in therapy
was performed in our study.
Forty-one percent of our proteinuric NIDDM patients with
biopsy-proven diabetic nephropathy lacked diabetic retinopa-
thy as compared to 62% and 60% of the proteinuric NIDDM
patients studied by Marshall and Alberti [23] and Schmitz and
Vaeth [24]. These findings are remarkable compared to IDDM
patients, where only a few percent of the proteinuric patients
are without retinopathy [25]. The mechanisms involved are
unknown. But special local conditions in the renal cortex must
prevail in order to account for the more accelerated develop-
ment of microangiopathy in the kidney as compared to the
retina in NIDDM patients with diabetic nephropathy. Hemody-
namic factors may well play a role, since several of the age
induced alterations in the kidney, such as nephron loss and
arteriolar hyalinosis causing impairment of the renal autoregu-
lation, can lead to a condition with elevated glomerular hydrau-
lic pressure. The high prevalence of systemic hypertension in
the elderly NIDDM patients may further aggravate this condi-
tion [11].
Recently, Grenfell et al [26] have suggested that diabetic
nephropathy can be diagnosed clinically in NIDDM patients if
they have persistent proteinuria, diabetic retinopathy and no
clinical or laboratory evidence of kidney or renal tract disease
other than diabetic glomerulosclerosis. We have confirmed this
suggestion by demonstrating that all our proteinuric NIDDM
patients with diabetic retinopathy had diabetic glomeruloscler-
osis as the cause of albuminuria. On the other hand, lack of
retinopathy is a poor predictor of a non-diabetic kidney disease,
which is in contrast to the suggestion made in the past [26].
Albuminuric NIDDM patients without retinopathy require fur-
ther evaluation, that is, kidney biopsy, since the chance for a
diabetic or non-diabetic glomerulopathy is approximately fifty-
fifty.
Reprint requests to Hans-Henrik Parving, M.D., Steno Memorial &
Hvidore Hospital, Niels Steensens Vej 2, KD-2820 Gentofte, Denmark.
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